Verteporfin therapy of subfoveal minimally classic choroidal neovascularization in age-related macular degeneration: 2-year results of a randomized clinical trial.
Saved in:
| Title: | Verteporfin therapy of subfoveal minimally classic choroidal neovascularization in age-related macular degeneration: 2-year results of a randomized clinical trial. |
|---|---|
| Authors: | Azab M, Boyer DS, Bressler NM, Bressler SB, Cihelkova I, Hao Y, Immonen I, Lim JI, Menchini U, Naor J, Potter MJ, Reaves A, Rosenfeld PJ, Slakter JS, Soucek P, Strong HA, Wenkstern A, Su XY, Yang YC |
| Corporate Authors: | Visudyne in Minimally Classic Choroidal Neovascularization Study Group |
| Source: | Archives of ophthalmology (Chicago, Ill. : 1960) [Arch Ophthalmol] 2005 Apr; Vol. 123 (4), pp. 448-57. |
| Publication Type: | Clinical Trial; Clinical Trial, Phase II; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: American Medical Association Country of Publication: United States NLM ID: 7706534 Publication Model: Print Cited Medium: Print ISSN: 0003-9950 (Print) Linking ISSN: 00039950 NLM ISO Abbreviation: Arch Ophthalmol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Links: – Type: pdflink Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 15824216 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Verteporfin therapy of subfoveal minimally classic choroidal neovascularization in age-related macular degeneration: 2-year results of a randomized clinical trial. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Azab+M%22">Azab M</searchLink><br /><searchLink fieldCode="AU" term="%22Boyer+DS%22">Boyer DS</searchLink><br /><searchLink fieldCode="AU" term="%22Bressler+NM%22">Bressler NM</searchLink><br /><searchLink fieldCode="AU" term="%22Bressler+SB%22">Bressler SB</searchLink><br /><searchLink fieldCode="AU" term="%22Cihelkova+I%22">Cihelkova I</searchLink><br /><searchLink fieldCode="AU" term="%22Hao+Y%22">Hao Y</searchLink><br /><searchLink fieldCode="AU" term="%22Immonen+I%22">Immonen I</searchLink><br /><searchLink fieldCode="AU" term="%22Lim+JI%22">Lim JI</searchLink><br /><searchLink fieldCode="AU" term="%22Menchini+U%22">Menchini U</searchLink><br /><searchLink fieldCode="AU" term="%22Naor+J%22">Naor J</searchLink><br /><searchLink fieldCode="AU" term="%22Potter+MJ%22">Potter MJ</searchLink><br /><searchLink fieldCode="AU" term="%22Reaves+A%22">Reaves A</searchLink><br /><searchLink fieldCode="AU" term="%22Rosenfeld+PJ%22">Rosenfeld PJ</searchLink><br /><searchLink fieldCode="AU" term="%22Slakter+JS%22">Slakter JS</searchLink><br /><searchLink fieldCode="AU" term="%22Soucek+P%22">Soucek P</searchLink><br /><searchLink fieldCode="AU" term="%22Strong+HA%22">Strong HA</searchLink><br /><searchLink fieldCode="AU" term="%22Wenkstern+A%22">Wenkstern A</searchLink><br /><searchLink fieldCode="AU" term="%22Su+XY%22">Su XY</searchLink><br /><searchLink fieldCode="AU" term="%22Yang+YC%22">Yang YC</searchLink> – Name: AuthorCorporate Label: Corporate Authors Group: Au Data: <searchLink fieldCode="CA" term="%22Visudyne+in+Minimally+Classic+Choroidal+Neovascularization+Study+Group%22">Visudyne in Minimally Classic Choroidal Neovascularization Study Group</searchLink> – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%227706534%22">Archives of ophthalmology (Chicago, Ill. : 1960)</searchLink> [Arch Ophthalmol] 2005 Apr; Vol. 123 (4), pp. 448-57. – Name: TypePub Label: Publication Type Group: TypPub Data: Clinical Trial; Clinical Trial, Phase II; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Medical+Association%22">American Medical Association </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>7706534 <i>Publication Model: </i>Print <i>Cited Medium: </i>Print <i>ISSN: </i>0003-9950 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200039950%22">00039950 </searchLink><i>NLM ISO Abbreviation: </i>Arch Ophthalmol <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=15824216 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1001/archopht.123.4.448 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 448 Titles: – TitleFull: Verteporfin therapy of subfoveal minimally classic choroidal neovascularization in age-related macular degeneration: 2-year results of a randomized clinical trial. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Azab M – PersonEntity: Name: NameFull: Boyer DS – PersonEntity: Name: NameFull: Bressler NM – PersonEntity: Name: NameFull: Bressler SB – PersonEntity: Name: NameFull: Cihelkova I – PersonEntity: Name: NameFull: Hao Y – PersonEntity: Name: NameFull: Immonen I – PersonEntity: Name: NameFull: Lim JI – PersonEntity: Name: NameFull: Menchini U – PersonEntity: Name: NameFull: Naor J – PersonEntity: Name: NameFull: Potter MJ – PersonEntity: Name: NameFull: Reaves A – PersonEntity: Name: NameFull: Rosenfeld PJ – PersonEntity: Name: NameFull: Slakter JS – PersonEntity: Name: NameFull: Soucek P – PersonEntity: Name: NameFull: Strong HA – PersonEntity: Name: NameFull: Wenkstern A – PersonEntity: Name: NameFull: Su XY – PersonEntity: Name: NameFull: Yang YC IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 04 Text: 2005 Apr Type: published Y: 2005 Identifiers: – Type: issn-print Value: 0003-9950 Numbering: – Type: volume Value: 123 – Type: issue Value: 4 Titles: – TitleFull: Archives of ophthalmology (Chicago, Ill. : 1960) Type: main |
| ResultId | 1 |
